东京热

东京热 Official Website

UNAIR researcher discusses rabies vaccine innovation with Indonesian and American scientists

Dr Arif Nur Muhammad Ansori attends The 9th Indonesian 鈥 American Kavli Frontiers of Science Symposium from August 7 to August 11, 2023, in Balikpapan, East Kalimantan. (Photo: Personal Doc.)
Dr Arif Nur Muhammad Ansori attends The 9th Indonesian 鈥 American Kavli Frontiers of Science Symposium from August 7 to August 11, 2023, in Balikpapan, East Kalimantan. (Photo: Personal Doc.)

UNAIR NEWS听鈥撀东京热 (UNAIR)聽continues to produce innovative researchers.聽One of the researchers is聽聽.聽The researcher and assistant lecturer聽聽discussed his innovation, Construction of Peptide-Based Vaccines with Indonesian Rabies Virus Glycoprotein: In Silico Approach聽with Indonesian and United States scientists.

Arif got this opportunity while attending聽The 9th聽Indonesian-American Kavli Frontiers of Science Symposium聽from August 7 to August 11, 2023, in Balikpapan, East Kalimantan.聽The event resulted from a collaboration between the Indonesian Academy of Sciences (AIPI) and聽the National Academy of Sciences聽(NAS), United States of America.

The alumnus of UNAIR Faculty of Veterinary Medicine doctoral program was the only UNAIR researcher present at聽The 9th聽Indonesian-American Kavli Frontiers of Science Symposium.聽This event is a prestigious forum for young scientists from Indonesia and the United States to work and build international collaborations.聽The participants received funding and career development guidance.

鈥淧articipants were less than 45 years old. This event provides guidance for conducting research, funding on an international scale, and career development guidance,鈥 explained Arif.

His innovation resulted from his concern looking at recent conditions in Indonesia. 鈥淐urrently, there are many cases in various regions in eastern Indonesia related to rabies that attacks animals and humans,鈥 he said.

New breakthrough rabies vaccine

From these problems, Arif took the initiative to design a rabies vaccine with a new breakthrough. 鈥淭his problem forces us to design a new, up-to-date, more significant breakthrough vaccine design. As we learned from the Covid-19 pandemic,鈥 he said.

Furthermore, the new breakthrough using genetic adjuvants can create a more optimal immune response in humans. 鈥淭his vaccine design is made with glycoprotein and uses isolates originating from Indonesia,鈥 he explained.

Arif revealed that he would conduct further research on the innovations he initiated. So that later this innovation will become a superior product. 鈥淩esearch is currently underway, starting with computational modeling. The advanced stages will make it an important product, 鈥渉e concluded. (*)

Author: Icha Nur Imami Puspita

Editor: Binti Quryatul M

QUICK LINKS

QUICK LINKS